Subject to shareholder approval at the subsequent Annual General Meeting (AGM), the Board of Directors of Sanofi Consumer ...
2d
TipRanks on MSNSanofi Consumer Healthcare India Releases Audited Financials for 2024Sanofi Consumer Healthcare India Limited ( ($IN:SANOFICONR) ) just unveiled an update. Sanofi Consumer Healthcare India ...
The company faced headwinds in the December 2024 quarter (Q4) as it reported a significant decline in earnings.
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Glenmark Pharmaceuticals rose 5.7% after the company reported a 300.2% sales growth in India for the third quarter.
Sanofi Consumer Healthcare India Ltd share price was down by -2.09% from the previous closing price of ₹4,756.85. Who are peers of Sanofi Consumer Healthcare India Ltd? The peers of Sanofi ...
Sanofi Healthcare India receives marketing authorization for Rezurock, a new treatment for chronic graft-versus-host disease patients in India.
Approved final Dividend of Rs. 55 per equity share having the face value of Rs. 10 /- each for the Financial Year ended 31st December, 2024 ...
Stay updated with the latest stock market news and live updates. Get real-time insights on Sensex Today, Nifty Live, stock market today, IPO news and more on Business Standard.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results